EUVIMEDEUVIMED entdecken
Open Access

Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis

Maulikkumar Patel iD, Cyril Pottier, Kang-Hsien Fan, Arda Cetin, Matthew Johnson, Muhammad Ali, Menghan Liu, Priyanka Gorijala, John Budde, Ruyu Shi, Ann D Cohen, James T Becker und 6 weitere

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Maulikkumar Patel und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Neurogenomics and Informatics, Washington University School of Medicine, 4444 Forest Park Ave, St. Louis, MO 63108, United …. Hauptthemen laut MEDLINE: Apolipoproteins E, Amyloidosis, Alzheimer Disease, Lipid Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCCIH NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid-PET imaging tracks the accumulation of amyloid beta (Aβ) deposits in the brain. Amyloid plaques accumulation may begin 10 to 20 years before the individual experiences clinical symptoms associated with Alzheimer’s diseases (ad). Recent large-scale genome-wide association studies reported common risk factors associated with brain amyloidosis, suggesting that this endophenotype is driven by genetic variants. However, these loci pinpoint to large genomic regions and the functional variants remain to be identified. To identify new risk factors associated with brain amyloid deposition, we performed whole-genome sequencing on a large cohort of European descent individuals with amyloid PET imaging data (n = 1,888). Gene-based analysis for coding variants was performed using SKAT-O for amyloid PET as a quantitative endophenotype that identified genome-wide significant association for APOE (P = 2.45 × 10−10), and 26 new candidate genes with suggestive significance association (P < 5. 0 × 10−03) including SCN7A (P = 7.31 × 10−05), SH3GL1 (P = 7.56 × 10−04), and MFSD12 (P = 8.51 × 10−04). Enrichment analysis highlighted the lipid binding pathways as associated with Aβ deposition in brain driven by PITPNM3 (P = 4.27 × 10−03), APOE (P = 2.45 × 10−10), AP2A2 (P = 1.06 × 10−03), and SH3GL1 (P = 7.56 × 10−04). Overall, our data strongly support a connection between lipid metabolism and the deposition of Aβ in the brain. Our study illuminates promising avenues for therapeutic interventions targeting lipid metabolism to address brain amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoproteins EAmyloidosisAlzheimer DiseaseLipid MetabolismHumansGenome-Wide Association StudyMaleFemaleWhole Genome SequencingBrainGenotypeAgedMiddle AgedPositron-Emission TomographyAmyloid beta-PeptidesGenetic Predisposition to DiseasePolymorphism, Single Nucleotide

Stichwörter der Autor:innen

APOEAmyloid-PETBrain amyloidosisLipidWhole Genome Sequencing

Substanzen

Apolipoproteins EApoE protein, humanAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Psychiatry, Neurogenomics and Informatics, Washington University School of Medicine, 4444 Forest Park Ave, St. Louis, MO 63108, United States.
  • Department of Psychiatry, Neurogenomics and Informatics, Department of Neurology, Washington University School of Medicine, 4444 Forest Park Ave, St. Louis, MO 63108, United States.
  • Department of Human Genetics, University of Pittsburgh, 130 De Soto St, Pittsburgh, PA 15261, United States.
  • Department of Psychiatry, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA 15213, United States.
  • Department of Neurology, University of Pittsburgh, 3471 Fifth Avenue, Pittsburgh, PA 15213, United States.
  • Department of Neurology, Hope Center for Neurologic Diseases, Section on Aging & Dementia, Institute of Clinical and Translational Sciences, Knight Alzheimer Disease Research Center Washington University School of Medic…

ORCID-Profile: Maulikkumar Patel

Förderung

  • NIA NIH HHS
  • NCCIH NIH HHS
  • National Institute on Aging
  • National Institute of Health

Zitieren

APA

Patel, M., Pottier, C., Fan, K. H., Cetin, A., Johnson, M., Ali, M., Liu, M., Gorijala, P., Budde, J., Shi, R., Cohen, A. D., Becker, J. T., Snitz, B. E., Aizenstein, H., Lopez, O. L., Morris, J. C., Kamboh, M. I., & Cruchaga, C. (2025). Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf017

Vancouver

Patel M, Pottier C, Fan KH, Cetin A, Johnson M, Ali M, et al. Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf017

BibTeX
@article{Patel2025,
  author = {Patel, Maulikkumar and Pottier, Cyril and Fan, Kang-Hsien and Cetin, Arda and Johnson, Matthew and Ali, Muhammad and Liu, Menghan and Gorijala, Priyanka and Budde, John and Shi, Ruyu and Cohen, Ann D and Becker, James T and Snitz, Beth E and Aizenstein, Howard and Lopez, Oscar L and Morris, John C and Kamboh, M Ilyas and Cruchaga, Carlos},
  title = {Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf017}
}
Kostenlos starten →